Cart
sales@molnova.com
UNC0064-12
CAS No. 1430089-64-7
UNC0064-12( UNC0064-12, UNC-0064-12, UNC 0064-12, UNC006412 )
Catalog No. M11817 CAS No. 1430089-64-7
2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 236 | In Stock |
|
| 5MG | 235 | In Stock |
|
| 10MG | 351 | In Stock |
|
| 25MG | 591 | In Stock |
|
| 50MG | 823 | In Stock |
|
| 100MG | 1107 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUNC0064-12
-
NoteResearch use only, not for human use.
-
Brief Description2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1.
-
Description2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1, Page 71; multikinase inhibitor and has a -NH2 terminal linker for further synthesis.
-
In Vitro——
-
In Vivo——
-
SynonymsUNC0064-12, UNC-0064-12, UNC 0064-12, UNC006412
-
PathwayAngiogenesis
-
TargetVEGFR
-
RecptorVEGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1430089-64-7
-
Formula Weight364.45
-
Molecular FormulaC19H24N8
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESNCCCNC1=CC=C(NC2=NC=CC(NC3=NNC(C4CC4)=C3)=N2)C=C1
-
Chemical NameN2-[4-[(3-Aminopropyl)amino]phenyl]-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.MULTIPLEXED KINASE INHIBITOR BEADS AND USES THEREOF. Patent Application WO/2013/055780 Kind Code: A1
molnova catalog
related products
-
Fargesin
Fargesin as a potential β1AR antagonist through cAMP/PKA pathway could protect against myocardial ischemia/reperfusion injury in rats.
-
Tyrphostin AG1433
Tyrphostin AG1433 is an inhibitor of tyrosine kinases and also a dual inhibitor of PDGFRβ(IC50s = 5.0 μM) and VEGFR-2 (Flk-1/KDR)(IC50s = 9.3 μM).
-
Vatalanib free base
A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ.
